ET NEWS

Jewar’s realty market is flying high as the much-awaited Noida International Airport (NIA) was inaugurated by Prime Minister Narendra Modi on Saturday. An investment of nearly Rs 11,200 crore ($1.2 billion) has been made in the first phase of the project, which will handle 12 million passengers annually. Once fully developed, the airport will have a total capacity of 70 million passengers.Billed as India’s largest upon completion, the six-runway airport is planned across 7,200 acres and counts Zurich Airport International AG as its sole investor.ALSO READ: PM Modi inaugurates Noida International Airport, Delhi-NCR’s second international airport at JewarIt is one of the biggest projects in India’s infrastructure overhaul that has seen billions being poured into building bridges, highways, ports and airports. The success of large-scale projects with foreign investment, such as the Jewar airport, is crucial for India’s economy to continue attracting overseas capital.The Jewar facility is banking on its strategic location in Uttar Pradesh and proximity to Agra, home to the Taj Mahal. About 174 acres of cargo and warehousing belt is also being planned around the airport. Several private firms, including the Adani Group, are bidding for the construction of a logistics hub.Ambitious industrial plans in the area are expected to bring more footfalls to the new airport. These include a Foxconn semiconductor facility, a solar manufacturing hub, and new factories by wire and cables maker Havells India Ltd. as well as agri-machinery maker Escorts Kubota Ltd.ALSO READ: Noida International Airport: Here’s everything you need to know about India’s newest international airport“The Noida International Airport is set to emerge as a powerful gateway for the state, significantly enhancing global connectivity and attracting investments across sectors. We anticipate a strong ripple effect on the real estate market, with property values witnessing a steady upward trajectory in the coming years,” said Manoj Gaur, CMD, Gaurs Group.Gurugram playbook or a new script?Comparisons between the new airport corridor and Gurugram’s growth story are rising, with a key question: Can it replicate that trajectory?For decades, development was concentrated in a few dominant nodes, primarily Gurugram and parts of Noida, said Mohit Batra, Regional Director, Realistic Realtors. The emergence of the Yamuna Expressway belt signals a shift toward a more distributed model, he added.“What we are seeing now is the emergence of multiple growth nodes. Jewar has the potential to become an independent economic centre rather than just an extension of Noida.”The corridor is already seeing strong traction, with growth patterns evolving. It is expected to draw multinational and domestic companies to the NCR’s satellite city, boosting demand for Grade-A office space and luxury housing, experts said.They project Grade-A office leasing in Noida at 2–3 million sq ft annually—about a quarter of Delhi-NCR activity—from this year, supported by upcoming infrastructure projects that will improve connectivity with Gurugram and Delhi.Noida has delivered nearly fivefold returns over the past six years in some micro-markets, driven by infrastructure expansion, policy support and rising demand.According to InvestoXpert Advisors, the Yamuna Expressway has emerged as NCR’s strongest real estate corridor, with apartment prices rising 158% (Rs 3,950 to Rs 10,200 per sq ft) between 2020 and 2025, while plot prices surged 536% (Rs 1,650 to Rs 10,500 per sq ft).Prices take offAccording to Square Yards, property prices near the upcoming Noida International Airport are expected to rise sharply, with plot values likely to increase by 28% and apartment prices by 22% over the next two years.Over the past five years, apartment prices have nearly tripled, while plot values have grown about 1.5 times, with some micro-markets seeing up to fivefold gains. This reflects strong investor interest driven by infrastructure development.The government is pushing an aerotropolis model, similar to global hubs like Amsterdam’s Schiphol Airport, integrating aviation with commercial, industrial, logistics and residential ecosystems to create self-sustaining urban centres.“Before construction accelerated on the Jewar airport project, Noida’s real estate market lagged behind other NCR markets due to delays and developer challenges,” said Sunita Mishra, Vice-President – Research & Insights, Square Yards.With the airport nearing operations, the region is expected to drive the next phase of NCR’s real estate growth, turning the Yamuna Expressway into a key investment destination.Airline test aheadUltimately, an airport’s success hinges on airline participation, a challenge in India’s aviation market where IndiGo and Air India together control nearly 90% market share.The Jewar airport will also compete directly with the existing Indira Gandhi International Airport to attract carriers. This contrasts with the Adani Group, which operates both Mumbai’s existing and upcoming Navi Mumbai airports, giving it greater leverage in securing airline partnerships.India’s major carriers—including IndiGo, Akasa Air and Air India Express—have shown interest in operating from Jewar, according to Yamuna Expressway Industrial Development Authority official Shailendra Bhatia. To attract airlines, authorities have lowered airport charges and cut VAT on jet fuel to 1%, compared with around 25% at Delhi airport.IndiGo had earlier signed an agreement to be the airport’s launch carrier in November 2023.For now, locals are watching closely to see how the new airport shapes economic opportunities and daily life in the region.

The primary market will see a quiet week ahead, with no new IPOs lined up in either the mainboard or SME segments. In the holiday-shortened week, focus will be on the listing of Coal India’s subsidiary, Central Mine Planning and Design Institute Ltd (CMPDI). Additionally, six companies are set to debut on the bourses following their public issues — three from the mainboard segment and the remaining from the SME space.Emiac Technologies IPOThe SME IPO of Emiac Technologies, which opened on Friday, will resume its public bidding in the coming week. The issue closes on Wednesday, April 8. The issue was subscribed 33% on the opening day.The company plans to raise Rs 31.75 crore through the issue which is entirely a fresh issuance of equity shares. Ahead of the opening, the grey market premium (GMP) indicated a muted listing.The company has set the price band at Rs 93–98 per share and investors can apply for a minimum of 1 lot which comprises 1,200 equity shares amounting to Rs 1,17,600.In the book-building issue, the company will issue 32.40 lakh equity shares aggregating up to Rs 31.75 crore.Mainboard listingsCMPDI IPOCentral Mine Planning will get listed on the exchanges on Monday, March 30. Ahead of its listing, the company's shares were commanding a grey market premium (GMP) of Rs 6-7 over the upper price band of Rs 172. The stock is expected to list around Rs 179, implying a gain of over 4%.The Rs 1,842 crore IPO CMPDI managed to sail through on the final day of bidding. By the end of Day 3, the issue was fully subscribed at 1.05 times the 7.97 crore shares on offer. The issue received over 8.36 crore share bids. Demand was mainly driven by Qualified Institutional Buyers (QIBs), who subscribed the IPO 3.48 times their quota, while Retail Individual Investors (RIIs) showed muted interest at just 33%. The non-institutional investors' (NII) quota also failed to get fully booked, managing only 35% subscription.Sai Parenteral’s IPOThe mainboard issue that closed on Friday, is expected to make its market debut on Thursday, April 2. Its GMP suggests a flat listing at Rs 392. The issue was subscribed 1.05 times over a three-day bidding period. It received over 78.80 lakh share bids against 75,22,486 equity shares available for booking.The demand was mainly driven by non-institutional investors' (NII) who subscribed the issue 2.36 times. Qualified Institutional Buyers (QIBs) subscribed the IPO 1.71 times their quota, while Retail Individual Investors (RIIs) hardly showed any interest, subscribing just 12% shares of the available quota.Powerica IPOThis mainboard issue also ended on Friday. It is expected to make its market debut on Thursday, April 2. Its GMP suggests a muted listing at Rs 395, implying a listing premium of around 1%.The issue was overall subscribed 1.45 times over a three-day bidding period. The demand was mainly driven by Qualified Institutional Buyers (QIBs) who subscribed the IPO 4.5 times of their quota, while Retail Individual Investors (RIIs) hardly showed any interest, subscribing just 14% shares of the available quota.The company planned to raise Rs 1,100 crore through the issue which is a combination of an offer for sale (OFS) and issuance of fresh equity. The company has set the price band at Rs 375–395 per share and retail investors can make applications for a minimum of 1 lot which comprises 37 equity shares amounting to Rs 14,615.Amir Chand Jagdish Kumar IPOThe Rs 440 crore IPO of Amir Chand Jagdish Kumar Exports ended on Friday. The offering was subscribed 3.41 times against the total 1.89 crore shares on offer.In the grey market, the IPO is commanding a premium of around 1.2%, or roughly Rs 3 above the issue price of Rs 212, suggesting a likely listing price near Rs 215.This IPO is entirely a fresh issue of 2.08 crore shares, aiming to raise Rs 440 crore. The company is set to list on both the NSE and BSE, with a tentative listing date of April 2, 2026.SME listingsThe SME issue Speciality Medicines which closed on March 24 will list on Monday. The stock is expected to list flat on the BSE SME.Tipco Engineering India IPO, ended on March 25. The stock will list on Wednesday April 1 on the BSE SME platform. The GMP revealed no listing gains.Highness Microelectronics IPO ended on Friday. Its GMP suggests a listing at a 20% premium over the issue price of Rs 120. The estimated listing price is Rs 145.(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)

New Delhi, Thermax on Saturday said its subsidiary Thermax Babcock & Wilcox Energy Solutions (TBWES) has secured a boiler package supply order worth approximately Rs 1,600 crore for an ultra-supercritical thermal power project. TBWES has secured the Rs 1,600 crore boiler package supply order valued from a leading thermal power projects company in Central India for a 1x800 MW ultra-supercritical thermal power plant, according to a company statement. The scope of work includes manufacturing, supply, commissioning, and performance testing of the boiler package, the statement said. "This order marks a significant breakthrough for Thermax and reinforces our proven capabilities in large-scale energy solutions. We thank our customer for their trust in Thermax and look forward to delivering this project with accelerated timelines and successful execution," said Ashish Bhandari, MD & CEO, Thermax, in a statement. TBWES provides equipment and solutions for generating steam for process and power through the combustion of various solid, liquid and gaseous fuels, as well as through heat recovery from turbine/engine exhaust and (waste) heat recovery from industrial processes.TBWES also offers heaters for various applications in the chemical, petrochemical and refinery segments. Its services arm offers renovation and modernisation solutions for old boilers and heaters.

Geopolitical shocks, like the ongoing conflict in West Asia, naturally unsettle markets. When headlines flash warnings of oil price spikes, shipping disruptions, and global “risk‑off” sentiment, it’s easy to lose sight of long‑term goals. We saw this not too long ago when the Nifty dropped nearly 3% intraday, driven by fears over crude supply routes and broader risk aversion. For India, which imports a large share of its crude and gas from this region, concerns about inflation, the current account deficit, and growth are entirely understandable.Yet history, both global and Indian, offers a reassuring lesson: markets are usually far more resilient than the gloom that dominates the headlines. From the Gulf War to the Russia‑Ukraine conflict in 2022, we have seen that while volatility spikes and drawdowns occur, broad indices have tended to recover as uncertainty fades. For long‑term investors, the real challenge is sticking to a disciplined plan that balances risk management with the ability to capture opportunities when they arise.What is Driving Markets Right Now?In the short term, three forces are shaping the market: the war, oil prices, and global liquidity. The disruption of key energy routes has pushed crude prices higher, unsettling risk assets worldwide. For India, this raises the risk of imported inflation and a wider current account deficit. At the same time, global central banks remain cautious, with a gradual path of rate cuts extending into 2026–27. This has kept Foreign Institutional Investors (FIIs) on the sidelines, even as domestic institutions continue to provide crucial support.Indian benchmarks have swung between sharp declines and swift rebounds. What often gets missed is that the real “pain” at the stock and sector level (especially in mid‑caps, small‑caps, and high‑beta financials) can be far deeper than the headline index suggests. In such an environment, thoughtful asset allocation and strict valuation discipline matter more than trying to time daily index movements.What Can History Teach Us About Markets and Wars?Looking back at decades of geopolitical events, we can spot three recurring patterns. During episodes such as the Cuban Missile Crisis, 9/11, and the Russia‑Ukraine war, markets did experience sharp volatility and drawdowns. Yet, as uncertainty eased and worst‑case scenarios were priced out, indices typically recovered within weeks to months. After the invasion of Ukraine in 2022, for example, the S&P 500 regained its initial losses within about a month, even as crude prices remained elevated.The key takeaway is that geopolitical shocks alone rarely derail long‑term equity returns. Lasting damage usually happens only when these shocks coincide with deep macroeconomic imbalances. Today, for India, the near‑term risk is less the conflict itself and more a sustained spike in oil prices and its secondary effects on inflation and the currency. Provided crude does not stay well above $100 for an extended period, the macro impact, while uncomfortable, is likely manageable for a growing economy with strong domestic demand.A Practical Framework for Indian InvestorsGiven this backdrop, the right response will naturally depend on your risk profile and investment horizon. That said, a few universal principles can help investors stay grounded and balanced.Do’s:Revisit asset allocation: Use this period to check whether your mix of equity, debt, and gold still matches your true risk tolerance. Portfolios that have drifted toward high‑beta or thematic bets may benefit from a course correction toward core, diversified holdings.Stagger investments: For those with surplus capital, systematic deployment, through STPs or SIP top‑ups, helps average into volatility without trying to time the absolute bottom.Upgrade quality: Corrections often compress valuations for fundamentally strong businesses. Use the dip to rotate from speculative names into leaders with healthy balance sheets and pricing power.Maintain liquidity: Ensure 6–12 months of essential expenses are parked in safe, liquid instruments, so you’re not forced to sell equities in a downturn.Stick to a plan: Document your target allocation and review schedule. A structured quarterly check‑in helps you avoid impulsive decisions driven by fear or greed.Don’ts:Avoid leveraged “catch‑the‑falling‑knife” bets: Aggressively averaging down with borrowed money is a fast track to capital destruction, especially when news flow is uncertain and margin calls loom.Don’t overhaul long‑term plans: Selling quality equity exposure wholesale because of a geopolitical event risks missing the eventual recovery.Don’t ignore valuations: Not every stock that falls 20–30% is a bargain. Focus on businesses where temporary headwinds do not impair long‑term cash flows.Don’t panic‑stop SIPs: Systematic plans are designed for exactly this kind of environment. Halting them turns temporary paper losses into permanent losses of compounding potential.What Does the Future Hold?For Indian investors, the goal should be to protect long‑term objectives while using volatility to strengthen portfolio quality. In the base case, where the conflict remains contained and oil prices do not stay significantly elevated, the impact on India should be manageable. Even in a more adverse scenario, the right response is disciplined, systematic risk management, not extreme “all‑in or all‑out” moves.Over the next 12–24 months, I recommend a three‑step framework:Stabilise: Reaffirm your emergency buffers and pare down unnecessary debt, so decisions aren’t forced by stress.Systematise: Continue or enhance SIPs and use clear, predefined rules to guide your deployment.Capitalise: Use corrections to upgrade portfolio quality and, for those with capacity, consider calibrated allocations to dynamic asset‑allocation strategies.Wars and crises will come and go. India’s long‑term growth and financialisation story, however, is playing out over decades. For investors who stay aligned to that horizon, staying calm, staying liquid, and staying disciplined is likely to be the most rewarding strategy.

As India’s investing landscape undergoes a structural shift, the next phase of growth is increasingly being driven by investors from beyond the top cities.In an interaction with Kshitij Anand of ETMarkets Smart Talk, Nilesh D. Naik, Head of Investment Products at Share.Market, highlighted how the rise of ‘Bharat’—spanning tier II, tier III, and smaller towns—is reshaping the wealth management ecosystem.With deeper digital penetration and growing participation from B30 cities, he believes this segment will be instrumental in expanding India’s investor base from around 60 million to nearly 200 million over the next decade, while also redefining how platforms approach product design, education, and investor behaviour. Edited Excerpts –Kshitij Anand: Now that the access problem has been solved by digital apps, what specific psychological barriers are preventing retail investors from making those intelligent decisions?Nilesh D. Naik: You are right— from an access perspective, the problem has largely been solved over the last five to six years. But one of the key challenges today is the complexity involved in starting the investing journey. And I think that is where platforms need to spend a lot of time.For example, for people who have been investing in mutual funds, it may not be that difficult— mutual funds may come across as a very simple product.But for a first-time investor, with thousands of products available, how do you zero down on the right one? That remains a big challenge. Going forward, you will see a lot of platforms focusing on this area in a big way.Kshitij Anand: And how can a retail investor distinguish between a fund that is genuinely consistent and one that is simply riding a temporary market tailwind?Nilesh D. Naik: Yes, this is an interesting question and one of the key issues that has been widely discussed in the industry. The general tendency of customers is to go by performance— they look at three-year or one-year performance and invest accordingly.At least at PhonePe, we have tried to address this issue by not focusing too much on performance, but by highlighting the consistency of the product. When I say consistency, there are complex concepts like rolling returns and so on.We try to simplify these, do the heavy lifting at our end, and present a simple metric that helps customers see whether the product has been consistent over the long term in relative terms, compared to other schemes in the category.I think it is very important to shift the focus away from point-to-point returns, which are highly cyclical— not just at the market level, but even at the relative performance level. So yes, this is a key area to focus on.Kshitij Anand: And at PhonePe, you very much believe in the Bharat story. So, how is that evolving at PhonePe and in the wealth management space?Nilesh D. Naik: Yes, the strength of PhonePe is our distribution reach, and we have a very strong presence in tier II, tier III cities and beyond. Just to share some numbers with you—if you look at the mutual fund customers that we have, more than two-thirds of them are from B30 cities, beyond the top 30, as per the AMFI definition.And not just from a customer perspective, but even from an AUM perspective, this is very different from the industry numbers, where it is actually the other way around, at least in terms of assets. So, the participation that we have seen is very encouraging, and it motivates us to build more for that cohort.That is going to be the growth engine for the industry as well, in terms of moving from a 60 million customer base to, let us say, 200 million over the next decade or so.Kshitij Anand: And let me also get your perspective on this—in a market that is prone to sudden volatility, how can platforms move beyond just providing data and actually help engineer better investor behaviour?Nilesh D. Naik: Yes, it does not start with volatility. What you need to do is ensure that when the customer or investor is investing, at that stage itself, you offer the right kind of product mix. That will take away half the problem because when you invest in the wrong product, the volatility tends to be much higher.A classic example today is investors who have invested in small caps. For a first-time investor, the kind of volatility experienced there is very different from someone who started with a large-cap, index, or hybrid product.So, retaining a customer who has invested in core products is relatively easier compared to someone investing in small-cap or thematic products.However, when such situations arise, there cannot be a single solution that addresses the entire problem. Continuous education is very important. Having the right contextual education within the app is critical. The nudges you give to customers—guiding them on how certain actions may work against them—are also very important. And of course, customers learn through experience.No matter how much we educate them, experience cannot be replaced. The good thing is that many of these customers are in their 20s, which means over the next three to four years, if they continue investing, they will develop their own learning—and that is the best teacher.Kshitij Anand: Staying with the Bharat story, as investors spread into tier II and tier III cities, how do we ensure that intelligence is simplified enough to be accessible to first-time investors?Nilesh D. Naik: There are different ways to do this, but I can share what we have done at PhonePe Wealth to help customers. When it comes to shortlisting or identifying funds, there are three core parameters that we focus on.The first is the consistency of the fund’s performance. The second is risk. And the third is whether there is a method behind that performance. By method, I mean the style of the fund manager and how the product is managed.We have launched an interesting tool called CRISP, which stands for Consistency, Risk, and Investment Style of Portfolio. We understand that these are relatively complex concepts, so we simplify them by categorising factors such as consistency into high, medium, or low; and risk into acceptable or high levels, so that investors can make informed decisions.Lastly, we also explain how the product is managed—whether it follows a quality, value, or momentum style—so that customers can create the right mix of funds that complement each other.However, even with simplification, education remains critical. We are focusing a lot on educating customers about these concepts in a simple and accessible manner.Kshitij Anand: Do you feel there is any single mistake that investors usually make when selecting a fund or investing?Nilesh D. Naik: Two things I would highlight here. One is, of course, investing based on past performance. In fact, we have done several studies wherein, if you look at, say, the previous three-year ranking of funds in a category and compare it with the next three years—for example, 2019 to 2022 versus 2022 to 2025—and then look at the ranks, the rank correlation is actually close to zero.This means there is absolutely no correlation between the two, which tells you that investing based on past performance does not work. However, it is a common behaviour among customers to look at returns and invest, and this is where one of the biggest mistakes comes from the customer side.The second is the absolute lack of planning. It is like someone tells me that this is a good fund, and I invest without thinking about why I am investing or what my framework should be.Every investor, no matter how small the investment, needs a framework that they can refer back to, especially during times when markets are highly volatile. Otherwise, you will keep debating whether to add more equity or redeem. Having a framework helps.When I say framework, it means understanding that your investment is long term and defining the level of downside risk you can tolerate. For example, based on recent data, markets can fall by as much as 40% in a worst-case scenario.But if, as an investor, I cannot tolerate more than a 20% downside, then I would probably allocate 50–60% to equity and the rest to fixed income products, gold, etc. Now, whenever something happens in the market, you can go back to that asset allocation framework and assess whether you are still aligned with your plan.It is a very simple concept, and there can be many variations of it. But having a proper plan is extremely important, and this is something that is missing for most investors.(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

India’s metabolic therapy landscape is undergoing a structural shift following the patent expiry of semaglutide, triggering a rapid transition from a premium, innovator-led market to a highly competitive, volume-driven segment. Historically constrained by high prices and limited access, the category is now witnessing a sharp inflection in demand, supported by significant price erosion of nearly 85–90% and a surge in product launches.The addressable opportunity remains substantial. With an estimated 75–80 million obese individuals and a large proportion suffering from co-morbid conditions, the need for structured obesity management is becoming increasingly evident. GLP-1 penetration, which remained low due to patent protection, is now expected to rise meaningfully as affordability improves and distribution expands. Over the next 3–5 years, the market could scale to INR34–67 billion, driven by rising patient adoption and chronic therapy demand.A key growth driver is the expanding prescriber base. While endocrinologists and diabetologists remain primary stakeholders, adoption is increasingly being supported by cardiologists, gastroenterologists, gynaecologists, and other specialists due to the multi-system impact of obesity and metabolic disorders. This broadening ecosystem is expected to accelerate awareness, referrals, and prescription volumes, reinforcing long-term demand visibility.However, the sector faces structural challenges. The entry of over 10–15 players has intensified competition, leading to rapid market fragmentation and pricing pressures. Despite a large volume opportunity, individual revenue gains are likely to remain modest, with low single-digit contribution to overall sales for most participants. Limited prescription bandwidth—where physicians typically engage with only a handful of brands—further constrains market share potential, increasing the need for aggressive marketing and elevating promotional costs.Pricing dynamics also reflect a clear stratification, with premium, mid-tier, and mass-market strategies co-existing. While this enhances accessibility, it accelerates commoditisation, weighing on margins across the value chain. Additionally, companies risk diverting focus from established portfolios amid heightened competition in this segment.An emerging structural trend is the rising preference for next-generation therapies. Even as semaglutide drives awareness and category expansion, newer molecules with superior efficacy are witnessing faster uptake and stronger physician preference, indicating a potential shift in long-term market leadership.Overall, the GLP-1 segment in India presents a compelling volume-led growth opportunity underpinned by strong demand fundamentals. However, the combination of pricing pressure, intense competition, and limited differentiation suggests that value capture may remain constrained, making scale and execution critical in navigating this evolving landscape.Ajanta Pharma: Buy| Target Rs 3400Ajanta Pharma is preparing to launch generic semaglutide post patent expiry of Novo Nordisk’s Ozempic/Wegovy in India, while continuing to expand its portfolio in high-growth segments such as dermatology, pain management, and nephrology. Ajanta Pharma’s long-term growth is driven by its expanding presence in branded generics across India, US, Africa, and Asia, with a focus on chronic therapies and new launches supporting sustained demand and deeper penetration in high-growth markets. Management expects mid-teens revenue growth with EBITDA margins around 27%, supported by expansion in Asia and Africa, a strong US product pipeline, and strategic addition of medical representatives to drive execution.Sun Pharma: Buy| Target Rs 1940Sun Pharma's Innovation momentum remains a key growth pillar, with specialty and novel therapies scaling up meaningfully. USD1b+ innovative sales (ex-milestones) provide resilience against US pricing pressure, while strong domestic formulation execution, consistent market share gains, and ROW/EM stability underpin diversified, sustainable growth drivers. In 3QFY26, SUNP delivered in-line adjusted revenues and EBITDA 6% ahead of estimates, supported by robust DF growth and favorable mix. Margin expansion reflected execution strength, partly offset by continued weakness in US generics due to regulatory headwinds at select sites. We estimate EM+ROW revenues to reach INR230b over FY25-28 at 12% CAGR, while specialty sales grow 11% CAGR to USD1.7b. Sustained DF outperformance, rising innovative R&D intensity, and steady pipeline launches support earnings visibility.(The author is Siddhartha Khemka, Head of Research - Wealth Management, Motilal Oswal Financial Services) (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)